| scholarly article | Q13442814 |
| P50 | author | Jeffrey N Weiser | Q37378150 |
| P2093 | author name string | W Li | |
| Y Wang | |||
| Y Guo | |||
| H Shen | |||
| X Ni | |||
| B Jiang | |||
| Y Tian | |||
| G F Sonnenberg | |||
| P2860 | cites work | Complete Genome Sequence of a Virulent Isolate of Streptococcus pneumoniae | Q22065841 |
| IL-17 mediates immunopathology in the absence of IL-10 following Leishmania major infection | Q27335548 | ||
| Invariant natural killer T cells recognize glycolipids from pathogenic Gram-positive bacteria | Q27673052 | ||
| Attachment of capsular polysaccharide to the cell wall in Streptococcus pneumoniae | Q27678113 | ||
| Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates | Q28258300 | ||
| Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine | Q28306783 | ||
| Regulation of lung endoderm progenitor cell behavior by miR302/367 | Q28505583 | ||
| Trivalent pneumococcal protein recombinant vaccine protects against lethal Streptococcus pneumoniae pneumonia and correlates with phagocytosis by neutrophils during early pathogenesis. | Q53641472 | ||
| Role of interferon-γ in Vα14+ natural killer T cell-mediated host defense against Streptococcus pneumoniae infection in murine lungs | Q62735750 | ||
| Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice | Q79317500 | ||
| Isolation of CD4+ T cells from murine lungs: a method to analyze ongoing immune responses in the lung | Q80093379 | ||
| Serotype replacement in invasive pneumococcal disease: where do we go from here? | Q81408994 | ||
| Protection against Streptococcus pneumoniae serotype 1 acute infection shows a signature of Th17- and IFN-γ-mediated immunity | Q83149313 | ||
| Mucosal immunization with caseinolytic protease X elicited cross-protective immunity against pneumococcal infection in mice | Q84446900 | ||
| Protective contributions against invasive Streptococcus pneumoniae pneumonia of antibody and Th17-cell responses to nasopharyngeal colonisation | Q28744146 | ||
| Pandemic preparedness and response--lessons from the H1N1 influenza of 2009. | Q30210593 | ||
| Resistance to mucosal lysozyme compensates for the fitness deficit of peptidoglycan modifications by Streptococcus pneumoniae | Q33392682 | ||
| T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization | Q33820413 | ||
| Pertussis toxin improves immune responses to a combined pneumococcal antigen and leads to enhanced protection against Streptococcus pneumoniae | Q33899407 | ||
| CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization | Q33935327 | ||
| Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells | Q33946696 | ||
| Serotype replacement in disease after pneumococcal vaccination | Q34178363 | ||
| GMP-grade pneumococcal whole-cell vaccine injected subcutaneously protects mice from nasopharyngeal colonization and fatal aspiration-sepsis | Q34310321 | ||
| CD8+ cells enhance resistance to pulmonary serotype 3 Streptococcus pneumoniae infection in mice | Q34444975 | ||
| Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide | Q34492821 | ||
| Pathogenesis, treatment, and prevention of pneumococcal pneumonia | Q35010692 | ||
| Next generation pneumococcal vaccines | Q35028495 | ||
| Interferon-γ production by neutrophils during bacterial pneumonia in mice | Q35042522 | ||
| Optimal serotype compositions for Pneumococcal conjugate vaccination under serotype replacement | Q35097094 | ||
| Protection against Streptococcus pneumoniae lung infection after nasopharyngeal colonization requires both humoral and cellular immune responses | Q35154329 | ||
| Streptococcus pneumoniae colonisation: the key to pneumococcal disease | Q35681330 | ||
| Rates of acquisition of pneumococcal colonization and transmission probabilities, by serotype, among newborn infants in Kilifi District, Kenya | Q36053930 | ||
| Controlled inflammatory responses in the lungs are associated with protection elicited by a pneumococcal surface protein A-based vaccine against a lethal respiratory challenge with Streptococcus pneumoniae in mice. | Q36191618 | ||
| Influence of bacterial interactions on pneumococcal colonization of the nasopharynx | Q37058954 | ||
| The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease | Q37109940 | ||
| Characterization of protective mucosal and systemic immune responses elicited by pneumococcal surface protein PspA and PspC nasal vaccines against a respiratory pneumococcal challenge in mice | Q37190966 | ||
| Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice | Q37241352 | ||
| Nasopharyngeal carriage and transmission of Streptococcus pneumoniae in American Indian households after a decade of pneumococcal conjugate vaccine use | Q37490524 | ||
| CRTAM controls residency of gut CD4+CD8+ T cells in the steady state and maintenance of gut CD4+ Th17 during parasitic infection | Q37689388 | ||
| Mucosal immunization with recombinant fusion protein DnaJ-ΔA146Ply enhances cross-protective immunity against Streptococcus pneumoniae infection in mice via interleukin 17A. | Q37713240 | ||
| SOCS3 transactivation by PPARγ prevents IL-17-driven cancer growth | Q39160299 | ||
| The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease. | Q39910189 | ||
| Limited role of antibody in clearance of Streptococcus pneumoniae in a murine model of colonization | Q40017980 | ||
| Key role for respiratory CD103(+) dendritic cells, IFN-γ, and IL-17 in protection against Streptococcus pneumoniae infection in response to α-galactosylceramide | Q42717336 | ||
| The immune response to pneumococcal proteins during experimental human carriage | Q42944608 | ||
| Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine | Q43608796 | ||
| Lack of cross-protection against invasive pneumonia caused by heterologous strains following murine Streptococcus pneumoniae nasopharyngeal colonisation despite whole cell ELISAs showing significant cross-reactive IgG. | Q43778924 | ||
| Bacterial pathogens and death during the 1918 influenza pandemic | Q48924934 | ||
| Histone acetylation at the single-cell level: a marker of memory CD8+ T cell differentiation and functionality. | Q51886363 | ||
| Generation of CD8 T cell memory is regulated by IL-12. | Q51973127 | ||
| P433 | issue | 1 | |
| P921 | main subject | Streptococcus pneumoniae | Q221179 |
| P304 | page(s) | 250-259 | |
| P577 | publication date | 2016-04-27 | |
| P1433 | published in | Mucosal Immunology | Q15817743 |
| P1476 | title | Cross-protective mucosal immunity mediated by memory Th17 cells against Streptococcus pneumoniae lung infection | |
| P478 | volume | 10 |
| Q40109570 | A Combination of Recombinant Mycobacterium bovis BCG Strains Expressing Pneumococcal Proteins Induces Cellular and Humoral Immune Responses and Protects against Pneumococcal Colonization and Sepsis |
| Q46345007 | Alveolar T-helper 17 responses to streptococcus pneumoniae are preserved in ART-untreated and treated HIV-infected Malawian adults |
| Q92988718 | Animal Models of Pneumococcal pneumonia |
| Q90773608 | Biofilm formation and avian immune response following experimental acute and chronic avian cholera due to Pasteurella multocida |
| Q33734772 | Bronchiectasis in Children: Current Concepts in Immunology and Microbiology |
| Q41993540 | Heterologous prime-boost immunization with live SPY1 and DnaJ protein of Streptococcus pneumoniae induces strong Th1 and Th17 cellular immune responses in mice |
| Q89080565 | Immunogenicity and mechanisms of action of PnuBioVax, a multi-antigen serotype-independent prophylactic vaccine against infection with Streptococcus pneumoniae |
| Q88691581 | Integrative Physiology of Pneumonia |
| Q64076710 | Mechanisms of Naturally Acquired Immunity to |
| Q92891280 | Mesenchyme-free expansion and transplantation of adult alveolar progenitor cells: steps toward cell-based regenerative therapies |
| Q47649982 | Mucosal immunization with PspA (Pneumococcal surface protein A)-adsorbed nanoparticles targeting the lungs for protection against pneumococcal infection. |
| Q39145154 | Pathogenesis of severe pneumonia: advances and knowledge gaps. |
| Q57459066 | Protection against Staphylococcus aureus Colonization and Infection by B- and T-Cell-Mediated Mechanisms |
| Q89480592 | Recognition of conserved antigens by Th17 cells provides broad protection against pulmonary Haemophilus influenzae infection |
| Q40332060 | Reduced T-Helper 17 Responses to Streptococcus pneumoniae in Infection-Prone Children Can Be Rescued by Addition of Innate Cytokines |
| Q93011027 | Regenerative therapy based on miRNA-302 mimics for enhancing host recovery from pneumonia caused by Streptococcus pneumoniae |
| Q40209420 | Regionally compartmentalized resident memory T cells mediate naturally acquired protection against pneumococcal pneumonia. |
| Q89965550 | Respiratory Barrier as a Safeguard and Regulator of Defense Against Influenza A Virus and Streptococcus pneumoniae |
| Q54249832 | The roles of resident, central and effector memory CD4 T-cells in protective immunity following infection or vaccination. |
| Q33813222 | Transcriptomic Analysis on Responses of Murine Lungs to Pasteurella multocida Infection |
| Q94545406 | Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives |
| Q93093474 | Yap/Taz regulate alveolar regeneration and resolution of lung inflammation |
Search more.